Ancora Advisors, LLC Harrow Health, Inc. Transaction History

Ancora Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$13.84 - $21.46 $558,582 - $866,125	-40,360 Reduced 51.98%	37,290 $789,000
Q4 2022 Feb 14, 2023	SELL	$10.28 - $14.78 $483,879 - $695,694	-47,070 Reduced 37.74%	77,650 $1.15 Million
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $9,372 - $12,616	-1,630 Reduced 1.29%	124,720 $908,000
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $855,389 - $1.09 Million	126,350 New	126,350 $862,000
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $545,188 - $697,389	-80,530 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $684,505 - $966,360	80,530 New	80,530 $696,000

176

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $885M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.